TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024

March 14, 2024

https://www.globenewswire.com/news-release/2024/03/14/2846730/0/en/TFF-Pharmaceuticals-to-Participate-in-the-36th-Annual-Roth-Conference-March-17-19-2024.html

FORT WORTH, Texas, March 14, 2024 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that Harlan Weisman, M.D., Chief Executive Officer of TFF Pharmaceuticals will be presenting a corporate overview at the 36th Annual Roth Conference being held March 17-19, 2024 in Dana Point, California. Company management will also be participating in one-on-one meetings.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.